Biotech

All Articles

Aelis' marijuana use medicine fails period 2b, steering Indivior to re-think $100M choice

.Aelis Farma's hopes of safeguarding a quick, beneficial choice on a $100 million choice settlement ...

ProKidney stops phase 3 trial certainly not needed for cell therapy confirmation

.ProKidney has quit among a set of period 3 tests for its tissue treatment for renal condition after...

Vaxcyte surges on 'stunning' 31-valent PCV win versus Pfizer

.Vaxcyte revealed what experts referred to as "remarkable" stage 1/2 records for its 31-valent pneum...

Recursion's brain disease trial presents insufficient proof of effectiveness

.Recursion has stumbled by means of an early exam of its tech-enabled method to medication revelatio...

Acepodia, Pfizer click on with each other for chemistry-based cell therapy

.Contact it an instance of great chemistry: Acepodia, a biotech based on Nobel Prize-winning science...

Praxis epilepsy medication reduces confiscations in phase 2 hearing

.Practice Accuracy Medicines has racked up another midphase win in epilepsy this year, with its sodi...

Three execs resign as Dyne articles blended records for DMD applicant

.After getting away from a professional grip numerous years back, Dyne Therapeutics has uncovered br...

Arrowhead fires off phase 3 records in unusual metabolic health condition ahead of market clash with Ionis

.Arrowhead Pharmaceuticals has presented its own hand ahead of a potential showdown along with Ionis...

Pfizer, Valneva present lyme ailment go helpful for 2nd booster

.Pfizer and Valneva might possess concerning pair of even more years to stand by just before they ma...

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Permit's study a talk along with Ayla Ellison, Fierce Biotech Managing Editor as well as Michelle B...